Detalhe da pesquisa
1.
Duration of Device-Based Fever Prevention after Cardiac Arrest.
N Engl J Med
; 388(10): 888-897, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342119
2.
Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest.
N Engl J Med
; 387(16): 1456-1466, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027564
3.
Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial.
Crit Care
; 28(1): 28, 2024 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254130
4.
Combined effects of targeted blood pressure, oxygenation, and duration of device-based fever prevention after out-of-hospital cardiac arrest on 1-year survival: post hoc analysis of a randomized controlled trial.
Crit Care
; 28(1): 20, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216985
5.
Impact of Blood Pressure Targets in Patients With Heart Failure Undergoing Postresuscitation Care: A Subgroup Analysis From a Randomized Controlled Trial.
Circ Heart Fail
; : e011437, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38847097
6.
Predicting poor neurological outcomes following out-of-hospital cardiac arrest using neuron-specific enolase and neurofilament light chain in patients with and without haemolysis.
Eur Heart J Open
; 3(4): oead078, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646044
7.
Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial.
Intensive Care Med
; 49(12): 1467-1478, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943300